Searchable abstracts of presentations at key conferences in endocrinology

ea0056p334 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Evolution of the degree of glycemic control in a cohort of patients with type 2 diabetes mellitus. study to 26 weeks

Herranz-Antolin Sandra , Alvarez-de Frutos Visitacion , Torralba Miguel

Objective: To evaluate the evolution of glycemic control in a cohort of patients with type 2 diabetes mellitus (T2DM) after its assessment in endocrinology.Methods: Prospective cohort study. 465 patients with T2DM who were not followed up at an endocrinology clinic were included. This study was approved by the Ethics and Clinical Research Committee of the University Hospital of Guadalajara.Results: Mean age was 63.4±12.5 years...

ea0063p126 | Diabetes, Obesity and Metabolism 1 | ECE2019

Microvascular and macrovascular complications in a cohort of patients with type 2 diabetes mellitus

Herranz-Antolin Sandra , Frutos Visitacion Alvarez-de , Torralba Miguel , Biedma-Mendez Andrea

Objective: To assess the prevalence of complications In a cohort of patients with type 2 diabetes mellitus (T2DM).Material and methods: Prospective cohort study. 465 patients with T2DM who were not followed-up at an endocrinology clinic were included. The follow-up was carried out during 26 weeks. The prevalence of complications was evaluated throughout the study. This study was approved by the Ethics and Clinical Research Committee of the University Hos...

ea0041gp97 | Diabetes (2) | ECE2016

Real-world comparative effectiveness of liraglutide, exenatide once weekly and lisixenatide in patients with type 2 diabetes mellitus

Marco Martinez Amparo , Martinez Garcia Ana , Herranz Antolin Sandra , Lopez Gallardo Gemma , Jose Pines Corrales Pedro , Quilez Toboso Rosa , Aguirre Sanchez-Covisa Miguel , Joaquin Alfaro Jose

The improvement of glycemic control and body weight reduction by GLP-1 receptor agonist (GLP1RA) has been demostred in randomized clinical trials, but comparative studies of the efficacy of different GLP1RA in real world and clinical practice setting are limited.Objectives: To compare the efficacy of liraglutide (LIRA), exenatide once weekly (EQW), and lisixenatide (LIXI) treatment in a real-world and clinical practice setting.Meth...

ea0063ep93 | Pituitary and Neuroendocrinology | ECE2019

Etiology of syndrome of inappropriate antidiuretic in patients on parenteral nutrition: prospective multicenter study

Ortola Buigues Ana , Gomez Hoyos Emilia , Dolores Del Olmo Garcia Maria , Herrero Ruiz Ana , Alvarez Hernandez Julia , Tejera Perez Cristina , Herranz Antolin Sandra , Breton Lesmes Irene , Angel Martinez Olmos Miguel , De Luis Roman Daniel

Introduction: Syndrome of Inappropriate Antidiuretic (SIAD) is the most frequent cause of hyponatremia in parenteral nutrition (PN) patients. Moreover, SIAD may be caused by multiple etiologies (drugs; pulmonary, neurological or abdominal disorders; malignant disease; idiopathic…). Our objective was to evaluate the main etiologies of SIAD in patients receiving PN.Methods: Prospective, non-interventional, multicenter study in 19 Spanish hospitals. F...